Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies-Reference-Cited by-同舟云学术

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies

Published:2016-04-12 Issue:4 Volume:51 Page:1033-1043
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Barthélemy Nicolas R.¹²,Gabelle Audrey²³,Hirtz Christophe²,Fenaille François¹,Sergeant Nicolas⁴,Schraen-Maschke Susanna⁴,Vialaret Jérôme²,Buée Luc⁴,Junot Christophe¹,Becher François¹,Lehmann Sylvain²

Affiliation:

1. CEA, iBiTec-S, Service de Pharmacologie et d’Immunoanalyse, Laboratoire d’Etude du Métabolisme des Médicaments, Gif-sur-Yvette, France

2. CHU Montpellier, IRMB, hôpital St Eloi, Laboratoire de Biochimie Protéomique Clinique et CRB, INSERM-UM U1183, Montpellier, France

3. Centre Mémoire Ressources Recherche, CHU Montpellier, hôpital Gui de Chauliac, Montpellier. Université Montpellier I, Montpellier, France

4. Inserm, UMR 837, Alzheimer & Tauopathies, Centre de Recherche Jean-Pierre Aubert, Institut de Médecine Prédictive et de Recherche Thérapeutique, Faculté de Médecine, Univ. Lille Nord de France, Université de Lille II, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference36 articles.

1. Biochemistry of Tau in Alzheimer’s disease and related neurological disorders;Sergeant;Expert Rev Proteomics,2008

2. Role of tau protein in both physiological and pathological conditions;Avila;Physiol Rev,2004

3. Biomarker modeling of Alzheimer’s disease;Jack;Neuron,2013

4. Alzheimer disease therapy–moving from amyloid-beta to tau;Giacobini;Nat Rev Neurol,2013

5. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: Results from the Swedish Mortality Registry;Skillback;JAMA Neurol,2014

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease;Acta Neuropathologica;2024-01-06

2. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies;Molecular Neurobiology;2023-12-20

3. Tau-targeting therapies for Alzheimer disease: current status and future directions;Nature Reviews Neurology;2023-10-24

4. Advancing novel therapies for neurodegeneration through an innovative model for industry–academia collaborations: A decade of the Eisai–UCL experience;Drug Discovery Today;2023-10

5. Break and accelerator—The mechanics of Tau (and amyloid) toxicity;Cytoskeleton;2023-08-26